The Complete Guide to Business Succession and M&A for Hospitals and Medical Corporations

📖 Approx. 11 min readPublished: 2026.05.05 ／ Updated 2026.05.08

Ending Business Succession and Successor Issues for Hospitals and Medical Corporations with M&A

The retirement of directors due to aging and a shortage of successors are pressing issues facing Japan’s healthcare industry. Unlike M&A for general corporations, business succession for medical institutions requires extensive specialized knowledge encompassing medical law, medical corporation systems, medical fee schedules, licenses, and the impact on regional healthcare. Particularly for medical corporations, complex issues such as the presence or absence of equity stakes, the composition of members, and the handling of funds significantly influence the selection of successor candidates and the M&A structure. This article provides a comprehensive explanation from medical M&A experts, covering the current challenges in business succession for hospitals and medical corporations, the specific procedures for third-party succession (M&A), methods for calculating transfer prices, and points to consider regarding tax and legal matters. Our aim is to provide practical knowledge for directors and presidents of medical corporations struggling with a lack of successors, as well as for tax accountants, CPAs, and consultants supporting their clients’ business succession.

1. Current Situation and Challenges Surrounding Business Succession in Medical Institutions

According to surveys by the Ministry of Health, Labour and Welfare, the average age of physicians working in medical facilities is increasing annually, with the aging of clinic directors being a particularly serious situation. A survey by the Japan Medical Association also indicates that over half of practicing physicians are 60 years or older, making the absence of successors a major management challenge. While intra-family succession was once the norm, the dual hurdles of a child becoming a physician and having the willingness to inherit the family business mean that such cases are decreasing. Even if a successor candidate exists, succession often faces difficulties due to reasons such as choosing a career as a salaried physician or being unable to secure the funds to acquire the medical corporation.

Furthermore, recent revisions to medical fee schedules have had a significant impact on the revenue structure of medical institutions. The management environment is becoming increasingly complex and sophisticated due to the promotion of “regional healthcare visions” that reorganize the healthcare delivery system from highly acute care to recovery and community-based care, investments in healthcare DX (digital transformation), and infection control measures. Responding to these changes may require new management strategies and large-scale capital investments, leading some medical institutions to find continued operation difficult on their own. Against this backdrop, the number of medical corporations choosing third-party succession, i.e., medical M&A, is increasing.

Major Challenges in Business Succession for Medical Institutions

• Lack of Successors: Shortage of family members or internal candidates.
• Aging Population: Gap between retirement timing of directors/presidents and business continuity.
• Complex Management Environment: Revisions to medical fees, regional healthcare visions, DX investments.
• Insufficient Funding: Securing acquisition funds and capital investment funds for succession.
• Specific Issues for Medical Corporations: Equity stakes, funds, general meetings of members, licenses.

In response to these challenges, medical M&A can be an effective means to resolve successor issues, ensure the continuity of medical institutions, maintain employment for staff, and provide ongoing medical care to patients.

2. Business Succession Patterns for Hospitals and Medical Corporations and Their Characteristics

There are broadly three patterns of business succession for hospitals and clinics. Each has its advantages and disadvantages, and the optimal choice varies depending on the type of medical corporation (e.g., incorporated medical association, incorporated foundation) and the situation of the transferring party.

2-1. Intra-Family Succession

This is the most traditional method of succession, where a family member such as the spouse, son, or daughter of the director or president becomes the successor. While often considered the ideal form, it requires many conditions to be met, including the successor being a physician, having the intention to inherit the family business, and possessing management capabilities. In recent years, as sons and daughters do not necessarily aim to become physicians, or even if they do, they increasingly prioritize careers at university hospitals or in specialized fields, making intra-family succession more difficult to achieve. Even if a family member becomes the successor, challenges may arise in financing the acquisition of the medical corporation or in smoothly transferring management rights (e.g., approval at a general meeting of members, election of a new director).

2-2. Non-Family (Internal) Succession

This pattern involves a current salaried physician, vice director, or a trusted head nurse becoming the successor. Since long-serving staff who have contributed to the medical institution take over management, there is an advantage in maintaining relationships with medical staff and patients. Furthermore, as they understand the operational policies and philosophy of the medical institution, a smooth handover can be expected. However, the biggest hurdle is how the successor candidate will finance the purchase of the medical corporation or its assets (real estate, medical equipment, etc.). Generally, the net assets and goodwill of medical corporations tend to be high, making it difficult to secure financing from financial institutions or use personal funds, which often prevents succession from being realized.

2-3. Third-Party Succession (Medical M&A)

This pattern involves transferring the medical institution to an external medical corporation, clinic, business company, or individual physician. It has rapidly become the most realistic and effective option for medical institutions facing a lack of successors. In third-party succession, the acquiring party provides the acquisition funds, so the transferring party has no financial burden. Additionally, by utilizing specialized M&A intermediaries, the process from finding a buyer to negotiation, contracting, and handover can proceed smoothly. The transferring party can secure funds for their post-retirement life by receiving a fair transfer price. Furthermore, by having the acquiring party take over management, the continuity and development of the medical institution’s long-cultivated brand, know-how, and regional healthcare delivery system can be expected. The maintenance of employment for staff and the continuation of medical care for patients are also important conditions negotiated in M&A agreements, so succession can often proceed with peace of mind.

Comparison Item	Intra-Family Succession	Internal Succession	Third-Party Succession (M&A)
Successor Candidate	Family Member (Child, Spouse, etc.)	Internal Staff (Salaried Physician, Head Nurse, etc.)	External Medical Corporation, Individual Physician, Business Company
Financing	Family Burden, Financial Institution Loans	Successor Candidate Burden, Financial Institution Loans	Acquiring Party Burden
Inheritance of Philosophy/Culture	Relatively Easy	Relatively Easy	Negotiation and PMI (Post Merger Integration) are Important
Transfer of Management Rights	Officer Change/Equity Transfer to Family Member	Officer Change/Equity Transfer to Successor	Share Transfer, Business Transfer, Merger, etc.
Transfer Price	None in Principle (Consider Gift Tax, etc.)	Based on Valuation	Based on Market Price (Expert Valuation)
Risks	Successor Training, Financing, Intra-family Disputes	Successor’s Financing, Management Skills	Employee/Patient Departure, PMI Failure

3. How to Proceed with Medical M&A: 6 Steps to Success

Medical M&A follows a process similar to general corporate M&A, but requires careful handling that takes into account the specific issues of medical institutions. Collaborating with experts (M&A advisors, lawyers, tax accountants, etc.) and proceeding according to the following steps is key to success.

1. Free Consultation and Initial Assessment:
   • First, consult with an M&A advisor and share your institution’s current situation (management status, succession objectives, desired conditions, etc.).
   • The advisor will explain market trends for medical M&A, success probabilities, approximate transfer price ranges, and how to proceed.
   • At this stage, a decision is made on whether to proceed with M&A.
2. Execution of Non-Disclosure Agreement (NDA) and Business Valuation:
   • Formally contract with the M&A advisor and execute a Non-Disclosure Agreement (NDA).
   • The transferring party will disclose information such as the medical institution’s financial statements, medical fee statements, facility standards, license information, and employee information to the advisor.
   • Based on this information, the advisor will calculate the business value (transfer price) of the medical institution, comprehensively evaluating net asset value, profitability (EBITDA, etc.), and future prospects.
3. Search for Potential Buyers and Matching:
   • The advisor will utilize their network and databases to search for potential buyers (other medical corporations, business companies, individual physicians, etc.) who meet the transferring party’s criteria.
   • Information is provided anonymously to potential buyers, and detailed information is only disclosed to those who express interest after signing an NDA.
   • After negotiating terms, the most suitable buyer, or one that shares the institution’s philosophy, is selected from among multiple candidates.
4. Execution of Letter of Intent (LOI) and Due Diligence (DD):
   • A Letter of Intent (LOI) outlining the transfer price, transfer structure, and key contract terms is executed with the potential buyer. While LOIs are often non-binding, they serve as important milestones in M&A negotiations.
   • Subsequently, the buyer conducts a detailed investigation (due diligence: DD) of the medical institution to be transferred. This involves examining financial, legal, tax, and medical aspects (facility standards, licenses, medical records, etc.) to identify any hidden risks.
5. Execution of Share Purchase Agreement (SPA) and Closing:
   • Based on the DD results, the final transfer price and contract terms are negotiated, and a Share Purchase Agreement (SPA) or Business Transfer Agreement is executed.
   • The agreement details the subject of transfer, price, payment method, representations and warranties, confidentiality obligations, non-compete clauses, employee treatment, and transfer of licenses.
   • Following the execution of the agreement, after submitting notifications to relevant authorities and completing the transfer of licenses, the final transaction is executed (closing).
6. PMI (Post Merger Integration) and Post-Succession Management:
   • After closing, the acquiring party proceeds with the business integration (PMI) of the transferred medical institution.
   • This involves integrating and restructuring aspects such as employee employment, medical care system, IT systems, and accounting/legal frameworks.
   • The transferring party may also provide advice or handover support for a certain period as needed.

4. Transfer Price for Medical Institutions: For Appropriate Valuation

The transfer price of a medical institution is determined by comprehensively evaluating various factors, not just the value of the building or the market price of medical equipment, but also its future earning potential, brand strength, and regional credibility. Generally, the transfer price is considered to consist of the following three elements.

Calculating the transfer price requires specialized knowledge and experience, making it essential to engage M&A advisors or certified public accountants. It is particularly important to accurately grasp the unique valuation factors for medical institutions (maintenance of facility standards, stability of medical fee revenue, relationships with medical associations, etc.) and to negotiate a fair price.

5. Tax and Legal Considerations in Medical M&A

Medical institution M&A involves various tax and legal issues for both the transferring and acquiring parties. Understanding these in advance and working closely with experts to address them appropriately is crucial to prevent future troubles.

5-1. Capital Gains Tax (Transferring Party)

When a medical corporation (especially one with equity stakes) or an individual business owner transfers their business, capital gains tax is levied on the profit from the transfer. The tax treatment varies depending on the transfer structure (e.g., share transfer, business transfer, merger). For instance, if the equity stakes of a medical corporation with equity are transferred, the profit is divided into deemed dividends and capital gains, each subject to different tax rates. If an individual business owner transfers business assets, the profit is subject to separate taxation. The timing and calculation of taxes also change depending on how the transfer price is received (lump sum or installments), making thorough consultation with a tax accountant essential.

5-2. Specific Issues for Medical Corporation Systems

• Equity Stakes and Funds: For medical corporations with equity stakes, valuation and transfer procedures for these stakes are necessary. Options include transitioning to a medical corporation without equity stakes or merging. If funds have been contributed, their repayment or transfer must also be considered.
• Changes in Members and Directors: Procedures stipulated by the Medical Care Act must be followed, including resolutions at the general meeting of members and the appointment/dismissal of directors and auditors.
• Transfer of Licenses: Licenses necessary for operating a medical institution, such as establishment permits, designations as an insured medical institution, and various facility standard notifications, generally require a succession procedure. It is necessary to confirm in advance whether the acquiring party can obtain these licenses and proceed with the procedures.
• Medical Fee Claims: The agreement must clearly define whether medical fee claims from the M&A execution date onwards belong to the transferring or acquiring party.

5-3. Considerations for the Acquiring Party

• Breach of Representations and Warranties: If hidden liabilities or violations of laws and regulations not discovered during due diligence become apparent after the M&A execution, the acquiring party may suffer significant losses. Reviewing the representation and warranty clauses in the contract is important.
• Employee Employment: In principle, employee employment is maintained after M&A, but sufficient consultation with labor unions and employees is necessary regarding changes to working conditions and employment rules.
• Impact on Regional Healthcare: The acquiring party has a responsibility to take over the role of regional healthcare previously provided by the transferring party. Maintaining and strengthening the medical care system and establishing a system for continuous medical care for patients are required.

To address these complex issues, close collaboration with lawyers, tax accountants, and M&A advisors who are well-versed in medical M&A is indispensable. By receiving support from experts, risks can be minimized, and smooth business succession can be achieved.

6. Towards Successful Medical M&A

Business succession for hospitals and medical corporations is not merely a transfer of organization but a critical decision that influences the future of regional healthcare. When faced with the challenge of a lack of successors, third-party succession (medical M&A) offers a viable option for many medical institutions to ensure business continuity and achieve a stable retirement. The key to success lies in accurately assessing your institution’s current situation, clarifying your M&A objectives, and proceeding cautiously and steadily with the process alongside a trusted team of experts (M&A advisors, lawyers, tax accountants, etc.).

In particular, it is essential to understand the specific regulations, medical fee systems, and contributions to regional healthcare unique to medical institutions, and to properly incorporate these into the M&A structure. Establishing a consistent support system, from calculating the transfer price and managing tax and legal risks to post-M&A PMI (Post Merger Integration), is indispensable for successful business succession. To envision your institution’s future and continue contributing to regional healthcare, we encourage you to consult with medical M&A specialists.

---

For Medical Succession Consultations, Contact M&A Medical

M&A Medical is a specialized M&A and business succession support service for medical institutions. As an M&A support institution certified by the Small and Medium Enterprise Agency, we support the success of transfers for clinics and medical corporations struggling with a lack of successors, as well as strategic acquisitions, on a success fee basis.

• Initial consultation and preliminary assessment are free
• No upfront fees or monthly charges (success fee only)
• Strict confidentiality (proceeding after NDA execution)
• Support available nationwide in all 47 prefectures and for all medical specialties

Please consult us early, even in the initial stages of consideration, whether you “just want to know the market price,” “have no successor,” or are “considering joining a group.”

Apply for Free Consultation